Compare PBH & PTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBH | PTY |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.4B |
| IPO Year | 2004 | 2002 |
| Metric | PBH | PTY |
|---|---|---|
| Price | $45.10 | $11.05 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $67.80 | N/A |
| AVG Volume (30 Days) | 451.4K | ★ 1.7M |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $975,777,000.00 | N/A |
| Revenue This Year | $17.03 | N/A |
| Revenue Next Year | $6.06 | N/A |
| P/E Ratio | $76.54 | ★ N/A |
| Revenue Growth | ★ 36.77 | N/A |
| 52 Week Low | $42.62 | $10.65 |
| 52 Week High | $71.07 | $14.69 |
| Indicator | PBH | PTY |
|---|---|---|
| Relative Strength Index (RSI) | 39.28 | 37.74 |
| Support Level | $44.73 | N/A |
| Resistance Level | $49.79 | $11.92 |
| Average True Range (ATR) | 1.30 | 0.20 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 32.07 | 38.79 |
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on both public or private basis.